Advancing patient care in the evolving prostate cancer treatment landscape (HYBRID) - European Medical Journal

Advancing patient care in the evolving prostate cancer treatment landscape (HYBRID)

Urology

This Bayer-sponsored symposium titled ‘Advancing patient care in the evolving prostate cancer treatment landscape (HYBRID)’ took place on 3rd July 2022 as part of the European Association of Urology 2022 (EAU22) in Amsterdam, the Netherlands.

The symposium and hosting of this video were funded by Bayer.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.